<DOC>
	<DOCNO>NCT01832480</DOCNO>
	<brief_summary>The overall goal project determine influence patient treatment host factor repeat Trichomonas vaginalis ( TV ) infection among HIV-negative woman</brief_summary>
	<brief_title>Trichomonas Vaginalis Repeat Infections Among HIV Negative Women</brief_title>
	<detailed_description>This study phase III randomize clinical trial . HIV-negative woman test positive TV routine gynecological exam participate clinic refer nurse/study coordinator screen eligibility , provide description study , obtain write , inform consent ( N=700 ) . Subjects undergo audio computer assist self- interview ( ACASI ) , self-collect vaginal swab Trichomonas test InPouch NAAT , Gram stain testing , future microbiome specimen . They randomize one two arm ; metronidazole ( MTZ ) 2 g single dose ( CDC recommend treatment regimen ) MTZ 500 mg BID 7-day dose ( CDC alternative treatment regimen ) . All enrol woman schedule follow-up visit four week post treatment completion ( window 3-13 week ) .</detailed_description>
	<mesh_term>Vaginitis</mesh_term>
	<mesh_term>Trichomonas Infections</mesh_term>
	<mesh_term>Trichomonas Vaginitis</mesh_term>
	<criteria>female English speaking &gt; = 18 year old HIVinfected unable provide inform consent pregnant breast feeding treat provider BV visit</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Trichomonas vaginalis</keyword>
	<keyword>metronidazole</keyword>
</DOC>